Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 88150 42 9. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303006B reveals a safer, cost-effective route for amlodipine intermediates, eliminating hazardous NaH and ensuring stable supply chains for global pharma manufacturers.
Patent CN112010801B reveals a metal-free reduction method for amlodipine base, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.